Tag: Nnrti

First approved in 2018, Biktarvy represents a newer generation of HIV treatment compared to the older regimen Atripla. This comparison explores what is the difference between Atripla and Biktarvy, from active ingredients to overall patient experience.

Atripla, a discontinued fixed-dose combination therapy, contains three distinct antiretroviral medications that work together to prevent the human immunodeficiency virus (HIV) from replicating. Though the branded version is no longer produced, its generic equivalent remains a key option for controlling HIV infection in adults and children.

As of 2025, an estimated 28 million people globally are receiving antiretroviral therapy (ART) to manage HIV. Two cornerstone classes of these life-saving drugs are NRTIs and NNRTIs. Understanding **what is the difference between NRTI and Nnrti** is crucial to appreciating how modern combination therapies work to control the virus.

According to the U.S. Food and Drug Administration (FDA), etravirine was approved for the treatment of HIV-1 infection in treatment-experienced adults in 2007. The other name for etravirine, the generic name for this HIV medication, is its brand name, Intelence®.

According to Pharmacy Practice News, the first generic version of etravirine was approved by the FDA in July 2021. The generic for etravirine has the same active ingredient as the brand-name drug Intelence, and is also known by its chemical name, etravirine.

Erestz is a specific formulation of antiretroviral medication containing three active substances: emtricitabine, rilpivirine, and tenofovir disoproxil fumarate. Used for the treatment of HIV-1 infection in adults, this combination drug helps reduce the amount of HIV in the body, improving the immune system and decreasing the risk of associated illnesses.

Etravirine, a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), was approved by the FDA in 2008 for treatment-experienced adults with HIV-1. Its key role is in combination therapy for patients who have developed resistance to earlier antiretroviral drugs, making it an essential tool for managing difficult-to-treat infections.

Antiretroviral therapy has transformed HIV from a fatal diagnosis to a manageable chronic condition for millions. So, **what type of drug is Complera?** It is a complete, three-drug combination antiretroviral medication in a single tablet, formerly prescribed to treat HIV-1 infection.